Publikationen (53) Publikationen von MARÍA JOSÉ SERRANO FERNÁNDEZ

2023

  1. Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer

    Cancer, Vol. 129, Núm. 4, pp. 521-530

  2. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer

    Biomarker Research

  3. Circulating tumor cells in cancer-risk populations as a cancer interception tool

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 113-129

  4. Comments on roles of circulating tumor cells in the metastatic cascade and tumor immune escape: Biology and clinical translation

    Journal for ImmunoTherapy of Cancer

  5. Editorial: Current trends and future perspectives about liquid biopsy

    Frontiers in Genetics

  6. Microfluidic amperometric immunosensor based on porous nanomaterial towards claudin7 determination for colorectal cancer diagnosis

    Talanta, Vol. 251

  7. Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  8. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 188

2022

  1. A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System

    Cancers, Vol. 14, Núm. 18

  2. Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance

    Frontiers in Cell and Developmental Biology

  3. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

    Theranostics, Vol. 12, Núm. 5, pp. 2150-2161

  4. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

  5. Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception

    Frontiers in Molecular Biosciences, Vol. 9

  6. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

    Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871

2021

  1. Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation

    Cancers, Vol. 13, Núm. 6, pp. 1-21

  2. Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (Isoflux) and imaging flow cytometry (imagestream)

    Cancers, Vol. 13, Núm. 24

  3. Sandwich-Type Electrochemical Paper-Based Immunosensor for Claudin 7 and CD81 Dual Determination on Extracellular Vesicles from Breast Cancer Patients

    Analytical Chemistry, Vol. 93, Núm. 2, pp. 1143-1153

2020

  1. Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

    Critical Reviews in Oncology/Hematology, Vol. 151

  2. Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

    Critical Reviews in Oncology/Hematology

  3. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

    Scientific Reports, Vol. 10, Núm. 1